Skip to main content

Breadcrumb

  1. Home

Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Assess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Positive NSCLC

Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery

Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens

AZD9291 US Expanded Access Program

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about AZD9291 US Expanded Access Program

Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 1/2 Study of X-396, an Oral ALK Inhibitor, in Patients With ALK-positive Non-Small Cell Lung Cancer

Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor

Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant

Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer

A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • Page 177
  • …
  • Next page Next
  • Last page Last
Subscribe to